Active

KST Pharma

Switched

BE0647823210

Rechtspersoon Private limited company 1 establishment

Chaussée Brunehaut (Que) 142, 7972 Beloeil Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Active for

10 year, 7 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 115,734

▼ 14% vs 2024

Profit

Healthy

€ 140

▼ 100% vs 2024

Debts

High

€ 147,395

▲ 151% vs 2024

KST Pharma from Beloeil, company number BE0647823210, closed financial year 2025 with a result of € 140 after tax. For that financial year KST Pharma recorded a gross margin of € 115,734 and equity of € 21,112. Compared with financial year 2024, the result moved from € 62,403 to € 140. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.

What happened at KST Pharma?

What happened at KST Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 140 (▼ 100% vs 2024). Source: NBB ↗
  • New establishment in Beloeil. KBO
  • KOEN STRAETMANS became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 34,644 profit in 2021 to € 140 profit in 2025.

Paid € 94,547 in corporate taxes since 2021.

Best year ever: 2023, with € 77,970 profit.

Paid out € 285,400 in dividends to the owners in total.

A new publication or filing at KST Pharma? We notify you, reason included.

Follow KST Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

KOEN STRAETMANS
KST Pharma

Behind KST Pharma is KOEN STRAETMANS. KOEN STRAETMANS is also behind FEBELCOFONDS.

See the full network in the app

Directors

According to the 2025 annual accounts

KOEN STRAETMANS

Director

Also active at: FEBELCOFONDS

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée Brunehaut (Que) 142

7972 Beloeil

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0647.823.210
VAT number
BE 0647.823.210
Registered office
Chaussée Brunehaut (Que) 142, 7972 Beloeil
Names & denominations
KST Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 February 2016
Peppol
Active · Active since 3 Dec 2025
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of KST Pharma?
The enterprise number of KST Pharma is BE0647823210.
What is the address of KST Pharma?
The registered office of KST Pharma is located at Chaussée Brunehaut (Que) 142, 7972 Beloeil.
When was KST Pharma founded?
KST Pharma was founded on 4 February 2016.
What is the main activity of KST Pharma?
The main activity of KST Pharma is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does KST Pharma have a website?
No website is currently known for KST Pharma.
How much profit did KST Pharma make in 2025?
KST Pharma posted a profit after taxes of € 140 in financial year 2025.
What is the revenue of KST Pharma?
As a small company, KST Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 115,734.
Where can I find the annual accounts of KST Pharma?
KST Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of KST Pharma?
According to the 2025 annual accounts, the directors of KST Pharma are: KOEN STRAETMANS.
Who owns KST Pharma?
Behind KST Pharma is KOEN STRAETMANS. KOEN STRAETMANS is also behind FEBELCOFONDS.